Search Results
Quinacrine 2HCl 100mg 100mg | Purity Not Available
Adooq Bioscience
Actinomycin D 50mg 50mg | Purity Not Available
Adooq Bioscience
Actinomycin D is a metabolite isolated from Streptomyces parvulus that binds to the GpC steps of DNA. The compound acts as an antibiotic and is more effective against gram-positive bacteria than gram negative bacteria.
More Information Supplier PageActinomycin D 25mg 25mg | Purity Not Available
Adooq Bioscience
Actinomycin D is a metabolite isolated from Streptomyces parvulus that binds to the GpC steps of DNA. The compound acts as an antibiotic and is more effective against gram-positive bacteria than gram negative bacteria.
More Information Supplier PageActinomycin D 100mg 100mg | Purity Not Available
Adooq Bioscience
Actinomycin D is a metabolite isolated from Streptomyces parvulus that binds to the GpC steps of DNA. The compound acts as an antibiotic and is more effective against gram-positive bacteria than gram negative bacteria.
More Information Supplier PageActinomycin D 10mg 10mg | Purity Not Available
Adooq Bioscience
Actinomycin D is a metabolite isolated from Streptomyces parvulus that binds to the GpC steps of DNA. The compound acts as an antibiotic and is more effective against gram-positive bacteria than gram negative bacteria.
More Information Supplier PageLDK-378 50mg 50mg | Purity Not Available
Adooq Bioscience
LDK378 is a highly selective, orally bioavailable and ATP-competitive small molecule inhibitor of ALK (Anaplastic Lymphoma Kinase), a receptor tyrosine kinase considered to be an important lung cancer drug target.
More Information Supplier PageLDK-378 5mg 5mg | Purity Not Available
Adooq Bioscience
LDK378 is a highly selective, orally bioavailable and ATP-competitive small molecule inhibitor of ALK (Anaplastic Lymphoma Kinase), a receptor tyrosine kinase considered to be an important lung cancer drug target.
More Information Supplier PageLDK-378 25mg 25mg | Purity Not Available
Adooq Bioscience
LDK378 is a highly selective, orally bioavailable and ATP-competitive small molecule inhibitor of ALK (Anaplastic Lymphoma Kinase), a receptor tyrosine kinase considered to be an important lung cancer drug target.
More Information Supplier Page